Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -102.06 | 46.67 |
PEG Ratio (TTM) | 1.34 | 8.50 |
P/S Ratio (TTM) | 2.23 | 16.41 |
P/B Ratio (TTM) | 2.12 | 16.74 |
P/FCF Ratio (TTM) | 26.63 | 48.81 |
Price to 5YR AVG Earnings Ratio | N/A | 15.24 |
Price to 5YR AVG FCF Ratio | N/A | 56.61 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.04% | 12.44% |
ROE (TTM) | -2.11% | 58.41% |
Net Profit Margin (TTM) | -2.07% | 24.83% |
ROIC 5YR AVG | N/A | -22.71% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 71.12% | 88.20% | N/A |
Revenue | 1.57% | 17.39% | N/A |
Net Income | 67.91% | 85.77% | N/A |
Cash Flow | 76.87% | 47.17% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.60 | 1.56 |
Quick Ratio (TTM) | 1.60 | 1.55 |
D/E Ratio (TTM) | 0.76 | 0.90 |
Interest Coverage (TTM) | 2.14 | 56.25 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 1.81 | 11.89 |
LTL to 5YR AVG FCF | N/A | 4.43 |
Shares Outstanding Growth 5YR AVG | N/A | 2.36% |